Showing results (201-210 of 209) with videos related to
Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 209 results.
Cell|June 9, 2023
Vaccine elicitation and structural basis for antibody protection against alphavirusesMatthew S Sutton, Sergei Pletnev, Victoria Callahan, et al.Cell|September 15, 2020
A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2Ahmed O Hassan, Natasha M Kafai, Igor P Dmitriev, et al.Biorxiv : the Preprint Server for Biology|June 9, 2020
Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animalsSeth J Zost, Pavlo Gilchuk, James Brett Case, et al.Biorxiv : the Preprint Server for Biology|November 19, 2025
Vaccine Elicitation of HIV-1 Neutralizing Antibodies Against Both V2 Apex and Fusion Peptide in Rhesus MacaquesHongying Duan, Joseph P Nkolola, Shuishu Wang, et al.Cell Reports|January 30, 2026
Vaccine elicitation of HIV-1 neutralizing antibodies against both V2 apex and fusion peptide in rhesus macaquesHongying Duan, Joseph P Nkolola, Shuishu Wang, et al.NPJ Vaccines|September 17, 2024
Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccineJoseph P Casazza, Amelia R Hofstetter, Pamela J M Costner, et al.The Lancet. HIV|May 23, 2025
Safety and pharmacokinetics of N6LS, a broadly neutralising monoclonal antibody for HIV: a phase 1, open-label, dose-escalation study in healthy adultsRichard L Wu, Katherine V Houser, Martin R Gaudinski, et al.Nature|July 16, 2020
Potently neutralizing and protective human antibodies against SARS-CoV-2Seth J Zost, Pavlo Gilchuk, James Brett Case, et al.Cell|October 29, 2024
Potent and broad HIV-1 neutralization in fusion peptide-primed SHIV-infected macaquesHua Wang, Cheng Cheng, James L Dal Santo, et al.Pageof 21